Carcinoembryonic antigen expression in stages I and II breast cancer: Its relationship with clinicopathologic factors
- 1 March 1996
- journal article
- Published by Elsevier in Human Pathology
- Vol. 27 (3) , 297-301
- https://doi.org/10.1016/s0046-8177(96)90072-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Prognostic factors in early breast carcinomaCancer, 1994
- Definition of the expression of the human carcinoembryonic antigen and non‐specific cross‐reacting antigen in human breast and lung carcinomasInternational Journal of Cancer, 1993
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Assessment of Antigen Damage in Immunohistochemistry: The Vimentin Internal ControlAmerican Journal of Clinical Pathology, 1991
- Imunohistochemical Demonstration of Carcinoembryonic Antigen (CEA) in 120 Mammary Carcinomas and its Correlation with Tumor Type, Grading, Staging Plasma-CEA, and Biochemical Receptor StatusPathology - Research and Practice, 1985
- Tissue carcinoembryonic antigen and estrogen receptor in human breast cancerInternational Journal of Cancer, 1985
- Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique.Journal of Clinical Pathology, 1980
- Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator.BMJ, 1979
- Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinomaHistopathology, 1978